Table 3.
Baseline characteristics of adolescent and young adult and older hepatocellular carcinoma patients after propensity score matching
|
Characteristic
|
|
Total, n = 690
|
AYA, n = 345 (50%)
|
Older, n = 345 (50%)
|
P
value
|
| Sex | 0.934 | ||||
| Male | 475 | 238 (69.0%) | 237 (68.7%) | ||
| Female | 215 | 107 (31.0%) | 108 (31.3%) | ||
| Race | 0.985 | ||||
| White | 371 | 185 (53.6%) | 186 (53.9%) | ||
| Black | 117 | 58 (16.8%) | 59 (17.1%) | ||
| Other | 202 | 102 (29.6%) | 100 (29.0%) | ||
| Marital status | 1.000 | ||||
| No married | 356 | 178 (51.6%) | 178 (51.6%) | ||
| Married | 334 | 167 (48.4%) | 167 (48.4%) | ||
| AJCC stage | 0.974 | ||||
| I | 230 | 115 (33.3%) | 115 (33.3%) | ||
| II | 127 | 64 (18.6%) | 63 (18.3%) | ||
| III | 197 | 98 (28.4%) | 99 (28.7%) | ||
| IV | 136 | 68 (19.7%) | 68 (19.7%) | ||
| Grade | 0.887 | ||||
| I | 217 | 109 (31.6%) | 108 (31.3%) | ||
| II | 271 | 136 (39.4%) | 135 (39.1%) | ||
| III | 188 | 93 (27.0%) | 95 (27.5%) | ||
| IV | 14 | 7 (2.0%) | 7 (2.0%) | ||
| Surgery | 1.000 | ||||
| No | 250 | 125 (36.2%) | 125 (36.2%) | ||
| Yes | 440 | 220 (63.8%) | 220 (63.8%) | ||
| Radiation | 1.000 | ||||
| No | 666 | 333 (96.5%) | 333 (96.5%) | ||
| Yes | 24 | 12 (3.5%) | 12 (3.5%) | ||
| Chemotherapy | 0.937 | ||||
| No | 437 | 219 (63.5%) | 218 (63.2%) | ||
| Yes | 253 | 126 (36.5%) | 127 (36.8%) |
AYA: Adolescent and young adult; HCC: Hepatocellular carcinoma; PSM: Propensity score matching; AJCC: American Joint Committee on Cancer; Grade I: Well differentiated; Grade II: Moderately differentiated; Grade III: Poorly differentiated; Grade IV: Undifferentiated.